Elevation of erythrocyte creatine post-puberty unrelated to erythrocyte lifespan: Implications from the lack of correlation between HbA1c and erythrocyte creatine.
Takahide Kokumai, Shigeru Suzuki, Satoru Takahashi, Toshika Okumiya, Masafumi Koga
{"title":"Elevation of erythrocyte creatine post-puberty unrelated to erythrocyte lifespan: Implications from the lack of correlation between HbA1c and erythrocyte creatine.","authors":"Takahide Kokumai, Shigeru Suzuki, Satoru Takahashi, Toshika Okumiya, Masafumi Koga","doi":"10.1016/j.cca.2025.120130","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>HbA1c levels are affected by both glycemia and erythrocyte lifespan. Erythrocyte creatine (EC) indicates mean erythrocyte age. Although EC levels differ between adolescent males and females, with higher levels in females, the mechanism remains unclear. We examined the EC and HbA1c levels in non-diabetic children.</p><p><strong>Methods: </strong>This study included 85 children aged 3-18 years (male/female: 44/41) without diabetes or anemia. Data on EC, age, HbA1c, glycated albumin (GA), casual plasma glucose (PG), and complete blood count were measured. We examined correlation among EC, age, and HbA1c levels separately in males and females. Additionally, we compared women with and without menstruation.</p><p><strong>Results: </strong>Age, EC, HbA1c, GA, and PG levels were comparable between the sexes. HbA1c levels were not correlated with age in either group (males: R = 0.063, p = 0.684; females: R = 0.112, p = 0.486). In males, EC levels were not correlated with age (R = 0.089, p = 0.567), but showed a negative trend with HbA1c (R = 0.281, p = 0.065). In females, EC levels were positively correlated with age (R = 0.557, p < 0.001), but not with HbA1c (R = 0.140, p = 0.383). Females with menstruation had higher EC levels (1.64 ± 0.43 µmol/g Hb) than those without menstruation (1.23 ± 0.23 µmol/g Hb, p = 0.004): however, HbA1c differences were not significant (5.44 ± 0.28 % vs, 5.41 ± 0.22 %, p = 0.771).</p><p><strong>Conclusions: </strong>No significant correlation was observed between EC and HbA1c levels in non-diabetic and non-anemic children. However, the discrepancy between HbA1c and EC levels in relation to age in females was observed. These findings indicate that in females, but not in males, EC may be falsely elevated irrespective of erythrocyte lifespan after puberty.</p>","PeriodicalId":10205,"journal":{"name":"Clinica Chimica Acta","volume":" ","pages":"120130"},"PeriodicalIF":3.2000,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica Chimica Acta","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.cca.2025.120130","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: HbA1c levels are affected by both glycemia and erythrocyte lifespan. Erythrocyte creatine (EC) indicates mean erythrocyte age. Although EC levels differ between adolescent males and females, with higher levels in females, the mechanism remains unclear. We examined the EC and HbA1c levels in non-diabetic children.
Methods: This study included 85 children aged 3-18 years (male/female: 44/41) without diabetes or anemia. Data on EC, age, HbA1c, glycated albumin (GA), casual plasma glucose (PG), and complete blood count were measured. We examined correlation among EC, age, and HbA1c levels separately in males and females. Additionally, we compared women with and without menstruation.
Results: Age, EC, HbA1c, GA, and PG levels were comparable between the sexes. HbA1c levels were not correlated with age in either group (males: R = 0.063, p = 0.684; females: R = 0.112, p = 0.486). In males, EC levels were not correlated with age (R = 0.089, p = 0.567), but showed a negative trend with HbA1c (R = 0.281, p = 0.065). In females, EC levels were positively correlated with age (R = 0.557, p < 0.001), but not with HbA1c (R = 0.140, p = 0.383). Females with menstruation had higher EC levels (1.64 ± 0.43 µmol/g Hb) than those without menstruation (1.23 ± 0.23 µmol/g Hb, p = 0.004): however, HbA1c differences were not significant (5.44 ± 0.28 % vs, 5.41 ± 0.22 %, p = 0.771).
Conclusions: No significant correlation was observed between EC and HbA1c levels in non-diabetic and non-anemic children. However, the discrepancy between HbA1c and EC levels in relation to age in females was observed. These findings indicate that in females, but not in males, EC may be falsely elevated irrespective of erythrocyte lifespan after puberty.
期刊介绍:
The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells.
The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal''s scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.